NUVOLI, Susanna Maria Francesca
 Distribuzione geografica
Continente #
NA - Nord America 7.847
EU - Europa 4.932
AS - Asia 2.028
OC - Oceania 37
Continente sconosciuto - Info sul continente non disponibili 30
SA - Sud America 22
AF - Africa 10
Totale 14.906
Nazione #
US - Stati Uniti d'America 7.808
UA - Ucraina 2.005
CN - Cina 1.751
SE - Svezia 1.006
DE - Germania 695
IT - Italia 482
FI - Finlandia 285
GB - Regno Unito 183
FR - Francia 135
HK - Hong Kong 104
KR - Corea 55
BE - Belgio 37
IN - India 36
CA - Canada 33
TR - Turchia 33
AU - Australia 31
EU - Europa 29
RO - Romania 20
BR - Brasile 14
PL - Polonia 13
JP - Giappone 11
IL - Israele 10
ES - Italia 9
IE - Irlanda 8
NL - Olanda 8
AT - Austria 7
IR - Iran 6
NZ - Nuova Zelanda 6
BG - Bulgaria 5
DK - Danimarca 4
ZA - Sudafrica 4
AE - Emirati Arabi Uniti 3
BY - Bielorussia 3
CH - Svizzera 3
CL - Cile 3
ID - Indonesia 3
LU - Lussemburgo 3
MX - Messico 3
RS - Serbia 3
SG - Singapore 3
BN - Brunei Darussalam 2
CR - Costa Rica 2
EG - Egitto 2
HU - Ungheria 2
IM - Isola di Man 2
MA - Marocco 2
MD - Moldavia 2
PE - Perù 2
RU - Federazione Russa 2
SK - Slovacchia (Repubblica Slovacca) 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AD - Andorra 1
BA - Bosnia-Erzegovina 1
CI - Costa d'Avorio 1
CO - Colombia 1
FK - Isole Falkland (Malvinas) 1
GL - Groenlandia 1
GR - Grecia 1
HR - Croazia 1
IQ - Iraq 1
IS - Islanda 1
JO - Giordania 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
MK - Macedonia 1
MN - Mongolia 1
MY - Malesia 1
PH - Filippine 1
PT - Portogallo 1
SA - Arabia Saudita 1
TH - Thailandia 1
TN - Tunisia 1
TW - Taiwan 1
VE - Venezuela 1
VN - Vietnam 1
Totale 14.906
Città #
Chandler 2.105
Jacksonville 1.290
Princeton 689
Dearborn 664
Nanjing 583
Wilmington 287
New York 274
Sassari 234
Nanchang 226
Boardman 211
Beijing 170
Shenyang 142
Ann Arbor 114
Woodbridge 98
Hong Kong 96
Hebei 91
Tianjin 90
Jiaxing 88
Changsha 67
Ashburn 63
Seoul 55
Kunming 46
Hangzhou 43
Norwalk 40
Brussels 37
San Francisco 37
Jinan 36
Zhengzhou 26
Toronto 24
Ningbo 23
Los Angeles 21
Izmir 20
Lanzhou 19
Alghero 18
Andover 17
Glasgow 16
Auburn Hills 15
Guangzhou 15
Taizhou 15
Edinburgh 14
Helsinki 14
Leawood 14
West Jordan 14
Cagliari 13
Milan 13
Changchun 12
Falls Church 11
Melbourne 11
Warsaw 11
Chicago 10
Hefei 10
London 10
Seattle 10
Agrigento 9
Canberra 9
Stockholm 9
Horia 8
Selargius 8
Tokyo 8
Amsterdam 7
Augusta 7
Shanghai 7
Vienna 7
Città Di Castello 6
Haikou 6
Rome 6
Salerno 6
San Mateo 6
Sydney 6
Dublin 5
Frankfurt am Main 5
Fuzhou 5
São Paulo 5
Tel Aviv 5
Ardabil 4
Copenhagen 4
Cormeilles-en-Parisis 4
Dallas 4
Hanover 4
Houston 4
Istanbul 4
Madrid 4
Markham 4
Mountain View 4
Sofia 4
Torino 4
Belgrade 3
Berlin 3
Birmingham 3
Dubai 3
Jinhua 3
Minsk 3
Newark 3
Nuremberg 3
Oklahoma City 3
Orani 3
Paris 3
Shaoxing 3
Washington 3
Bandar Seri Begawan 2
Totale 8.501
Nome #
Enzyme biosensors for biomedical applications: Strategies for safeguarding analytical performances in biological fluids 104
Underserved populations and bacterial and protozoal sexually transmitted infections: a lost health-care opportunity 86
The burden of HIV-Associated neurocognitive disorder (HAND) in post-HAART era: Amultidisciplinary review of the literature 85
99mTc-Tetrofosmin Pinhole-SPECT (P-SPECT) and Radioguided sentinel node (SN) biopsy and in breast cancer axillary lymph node staging 82
123I-ioflupane brain SPECT and 123I-MIBG cardiac planar scintigraphy combined use in uncertain parkinsonian disorders 68
99mTc HM-PAO Brain Spect Qualitative and Quantitative Analyses (QLA/QNA) In Fibromyalgia Syndrome (FMS) Treated With Hyperbaric Oxigen Therapy (HOT) 67
123I-FP-CIT SPECT in the diagnosis of Parkinson’s disease in early stage 66
Plasma levels of leptin in heavy obese subjects 66
The role of Tc-99m Tetrofosmin (T) SPECT in mediastinal lymph node metastasis detection in lung cancer (LC). A.Spanu, F.Ginesu, A.Farris, M.E.Solinas, G.Deiola, C.Bagella, P.Pirina, G.C.Ginesu, S.Nuvoli, P.Solinas and G.Madeddu. Eur J Nucl Med 1997 65
99mTc-tetrofosmin SPET in the detection of both primary breast cancer and axillary lymph node metastasis 64
Preoperative identification of residual breast tumor following neoadjuvant therapy: a breast-specific γ-camera (BSGC) planar scintigraphy and SPECT/CT comparative study. 64
Central nervous system involvement in systemic lupus erythematosus patients as revealed by brain MRI and SPECT. M.Piga, L.Satta, G. Sanna, G.L.Loi, M.Floris, A.Vacca, M.Laudadio, A.Careddu, C.Montaldo, A.Spanu, S.Nuvoli, G.Madeddu, A.Mathieu. Q J Nucl Med 1996, 40 (suppl 1): 18 63
99mTc-Tetrofosmin scan in non small cell lung cancer (NSCLC) 63
The role of 99mTc-tetrofosmin Pinhole-SPECT in breast cancer axillary lymph node staging 62
β-Endorphin and Cortisol Levels in Plasma and CSF Following Acute Experimental Spinal Traumas 62
The role of Tc-99m Tetrofosmin (T) SPECT in primary lung cancer detection 62
Breast scintigraphy with a breast specific gamma camera (BSGC) and dynamic breast magnetic resonance imaging (MRI) in the detection of primary breast cancer (BC): A comparative study 62
111InPentetreotide SPECT and SPECT/CT in non functioning gastroenteropancreatic neuroendocrine tumors (GEP). 62
111In-pentetreotide SPECT and SPECT/CT vs conventional imaging procedures (CIP) in non-functioning gastroenteropancreatic neuroendocrine tumor (GEP) patient management. 62
Iodine-123 Ioflupano brain SPECT in extra-pyramidal movement disorders of recent appearance 61
Tc 99m-Tetrofosmin scan in lung and breast cancer detection 61
The role of molecular breast imaging in predicting complete tumor response to treatment and residual tumor extent following neoadjuvant therapy 61
123I-FP-CIT brain SPECT: tracer uptake values of right putamen are the most discriminant to diagnose Parkinson’s disease. 61
Alzheimer disease (AD) and Lewy bodies dementia (LBD) differential diagnosis: a 123Ioflupane SPECT study. 60
The usefulness of SPECT scintimammography in multifocal/multicentric breast cancer detection 60
The value of preoperative molecular breast imaging for the size assessment of invasive carcinoma and ductal carcinoma in situ 60
Different impact of NNRTI and PI-including HAART on bone mineral density loss in HIV-infected patients 60
99mTcHMPAO brain SPECT qualitative and quantitative analysis in mild cognitive impairment. 59
Technetium-99m Tetrofosmin SPECT in primary breast cancer detection and axillary lymph node staging 59
99mTc-tetrofosmin planar scintimammography and SPECT in monitoring the response to neoadjuvant hormone or chemotherapy in locally advanced primary breast cancer (LAPBC) 59
123I-FP-CIT SPECT usefulness in early stage Parkinson’s Disease 59
Brain 18F-FDG PET qualitative and quantitative analyses in Atypical Parkinsonian Syndromes (APS) with Cognitive Clinical Symptoms (CCS) 59
131I-SPECT/CT in neck lymph node metastasis detection in patients with differentiated thyroid carcinomas (DTC) in long-term follow-up 59
131I SPECT/CT in the follow-up of differentiated thyroid carcinoma: incremental value versus planar imaging 58
99mTc-Tetrofosmin (TF) mammoscintigraphy in primary breast cancer (BC) detection: SPECT vs Planar 58
Bone Alkaline Phosphatase (BAP) related to Prostate Specific Antigen (PSA) in bone metastasis prostate cancer (PC) patients 58
A longitudinal study on bone metabolism in HIV patients treated with HAART. 58
131I-SPECT/CT in differentiating neck iodine fixing foci in patients with differentiated thyroid carcinoma (DTC). 58
ERPs and cerebral perfusion correlates in Mild Cognitive Impairment (MCI). 58
A longitudinal study of bone metabolism in patients with homozygous thalassaemia major 57
111In pentetreotide SPECT/CT in neuroendocrine tumor (NETs) diagnostic management. 57
Qualitative (QL) and 3D Quantitative (QN) analysis of 123I-Ioflupane SPECT in possible Alzheimer’s Disease (AD), Lewy Body Dementia (LBD) and Vascular Dementia (VD) differential diagnosis. 56
Role of Ca549 in patients with breast cancer 56
The usefulness of high resolution planar scintimammography with dedicated breast camera in the diagnosis of multifocal/multicentric primary breast cancer (BC) 56
The follow up of thyroidectomized patients with differentiated thyroid carcinomas (DTC):131 I-SPECT/CT incremental value than planar whole body scan 56
131I SPECT/CT in neck lymph node metastasis detection in patients with differentiated thyroid carcinoma (DTC). 56
The value of semiquantitative FDG-PET parameters in the diagnosis of solitary pulmonary nodules with pre-test intermediate likelihood of malignancy: a single-centre study 56
The usefulness of 99mTc-tetrofosmin SPECT in the detection of primary lung cancer 56
May ERP and SPECT investigations represent early markers of Mild Cognitive Impairment (MCI) 56
Artificial neural network classifiers provide cut-off values to differentiate PD and ET by 123I-FP-CIT SPECT. 56
Primary Progressive Aphasia (PPA) variants: a diagnostic brain 18F-FDG PET/CT study 56
The usefulness of 99mTc-tetrofosmin SPECT in the detection of intrathoracic malignant lesions 55
Tc-99m Tetrofosmin (T) SPECT in monitoring the response to treatment in lung cancer (LC) patients 55
The role of TC-99m Tetrofosmin SPECT in breast cancer diagnosis, axillary lymph node staging and follow up 55
123I-MetalodoBenzylGuanidine (123I-MIBG) cardiac scintigraphy in the differential diagnosis of neurodegenerative movements disorders 55
123I FP-CIT SPECT in early Parkinson’s disease 55
Cerebral and cerebellar diaschisis following carbamazepine therapy 55
111In-Pentetreotide SPECT/CT in neuroendocrine gastroenteropancreatic (GEP) tumors 55
Assessment of myocardial viability by Thallium-201 reinjection and nitrates 55
Differentiated thyroid carcinoma (DTC) follow up: a 131I-SPECT/CT study. 55
The role of 99mTc-tetrofosmin neck pinhole (P)-SPECT in the follow up of patients with differentiated thyroid carcinoma (DTC) 55
99mTc-tetrofosmin molecular breast imaging (MBI) with high resolution dedicated breast camera (DBC) and breast dynamic magnetic resonance imaging (MRI) in the preoperative local staging of primary breast cancer. 55
The usefulness of SPECT/CT and neck pinhole SPECT (P-SPECT) as complementary tools to planar parathyroid scintigraphy in hyperparathyroidism (HPT). 55
The clinical usefulness of CYFRA 21-1 in non small cell lung cancer (NSCLC) 54
99mTcHM-PAO and 123I-Ioflupane brain SPECT usefulness in cognitive and movement associated disorders. 54
Combined 123I-Iofuplane SPECT and 123I-MIBG cardiac scintigraphy use in Parkinson disease(PD) and vascular Parkinsonism(VP) differential diagnosis. 54
Tc-99m-tetrofosmin pinhole-SPECT (P-SPECT) and radioguided sentinel node (SN) biopsy and in breast cancer axillary lymph node staging 54
Breast cancer axillary lymph node metastasis detection by a high-resolution dedicated breast camera: a comparative study with SPECT and pinhole SPECT 54
(111) In-pentetreotide SPECT/CT in pulmonary carcinoid (PC) 54
99mTc-Tetrofosmin (T) SPECT in thorax metastatic mass (TMM) detection 54
The usefulness of 99mTc tetrofosmin scintigraphy in patients with breast cancer recurrences 53
Neuropsychophysiological findings in a case of long-standing overt ventriculomegaly (LOVA) 53
131I-SPECT/CT in differentiated thyroid carcinoma (DTC) 53
Bone mass loss in HIV patients treated with HAART 53
The role of Tc-99m Tetrofosmin (T) scan in the post-operative follow-up of breast cancer patients 53
Two 123I-Ioflupane brain SPECT semiquantitative methods to diagnose Parkinson's disease (PS) comparatively evaluated by support vector machine classifier (SVM) 53
The role of breast scintigraphy with breast-specific γ-camera (BSGC) and SPECT/CT in the preoperative identification of residual breast tumor and axillary lymph node metastases following neoadjuvant therapy 53
Body fat changes in HIV patients on highly active antiretroviral therapy (HAART): a longitudinal DEXA study. 53
Epidemiology, Clinical Aspects, Laboratory Diagnosis and Treatment of Rickettsial Diseases in the Mediterranean Area During COVID-19 Pandemic: A Review of the Literature 53
Qualitative (Q) and semiquantitative (SQ) brain 18FFDG PET analyses in primary progressive aphasia (PPA) variants 53
SPECT and PET serve as molecular imaging techniques and in vivo biomarkers for brain metastases 52
The role of planar scintimammography with high-resolution dedicated breast camera in the diagnosis of primary breast cancer 52
The usefulness of Ca549 in breast cancer 52
The assessment of breast cancer (BC) response to neoadjuvant therapy: a SPECT/CT study. 52
The Effects of Drugs on Verbal Fluency 52
The additional role of 18F-FDG PET/CT in prosthetic valve endocarditis 52
Brain SPECT imaging and Neuropsychological tests in Cognitive Impairments 52
Cerebral blood flow after carbamazepine therapy 52
Breast-specific imaging (BSGI) in predicting tumor response to treatment and in assessing residual tumor size following neoadjuvant therapy in locally advanced primary breast cancer. 52
Breast cancer (BC) preoperative staging: the role of Molecular Breast Imaging (MBI) with a high resolution dedicated breast camera (DBC.) 52
The usefulness of 111In-Pentetreotide SPECT/CT in pulmonary carcinoid tumors (PC) 52
Usefulness of bladder tumour antigen (BTA) and urinary bladder cancer test (UBC) in transitional cell blood cancer (TCC) diagnosis and follow-up 52
Pinhole-SPECT (P-SPECT) imaging in comparison with radioguided sentinel node (SN) biopsy in breast cancer (BC) axillary lymph node staging 52
Tc-99m Tetrofosmin (T) 360° SPECT and 180° Pinhole (P) SPECT in differentiated thyroid carcinoma (DTC) follow-up 52
Uremia, trapianto renale e cancro. Ruolo dei marcatori tumorali nella diagnosi e nel monitoraggio. 52
Neck lymph node metastases in patients with differentiated thyroid carcinoma (DTC) in long-term follow-up: a diagnostic 131I-SPECT/CT study 52
The role of 99mTc-tetrofosmin axillary pinhole-SPET (P-SPET) in non palpable axillary lymph node metastases from breast cancer (BC) 51
(111) In-pentetreotide SPECT/CT in gastroenteropancreatic (GEP) 51
123I-MIBG cardiac scintigraphy in discriminating Parkinson’s disease (PD) from vascular Parkinsonism (VP ) using classification tree( CIT ) classifier together with conventional quantitative analysis. 51
111In pentetreotide SPECT e SPECT/TC in non fuctioning gastroenteropancreatic tumors (GEP) 51
Totale 5.779
Categoria #
all - tutte 59.004
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 59.004


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019151 0 0 0 0 0 0 0 0 0 0 15 136
2019/20203.680 887 4 266 115 330 552 607 54 360 137 356 12
2020/20213.036 336 3 557 20 337 228 344 4 480 467 158 102
2021/20221.479 229 13 19 7 13 17 36 124 126 83 154 658
2022/20234.015 384 198 66 736 427 668 12 504 730 24 179 87
2023/20241.157 250 118 58 54 442 108 6 39 3 22 57 0
Totale 15.191